Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 795
Guide Official Revision Description Reason for Update
Version Date Number Of Change
acceptable and remove wait
time.
2025 08/27/2025 26. Medical Policy In Item 48. General
Systemic, revised CACI –
Weight Loss Management
Worksheet and CACI -
Prediabetes Worksheet
to add trade names and
remove substance use
disorder bullet.
2025 08/27/2025 27. Medical Policy In Pharmaceuticals, Weight
Loss Medications, revised to
add trade names and
removed bullet on substance
use disorder. Clarified if
taking insulin + weight loss
medication, see
www.faa.gov/go/ITDM
2025 08/27/2025 28. Medical Policy In Pharmaceuticals –
Glaucoma Medications
moved Rho Kinase Inhibitors
to CACI and added common
medication names.
2025 08/27/2025 29. Medical Policy In Pharmaceuticals, revised
Antidepressant Medications
moving vilazodone (Viibryd)
to conditionally acceptable.
2025 08/27/2025 30. Administrative SSRI Decision Path -1 and
Path – II, revised graph to
link to Antidepressant
Medications
2025 08/27/2025 31. Medical Policy In Pharmaceuticals, revised
Migraine Medication.
Clarified lasmiditan (Reyvow)
acceptable for abortive
treatment only. Added
acceptable combination
medications with 24-hour
post-dose observation and
eptinezumab (Vyepti).
2025 08/27/2025 32. Medical Policy In Item 46. Neurologic,
revised CACI – Migraine and
Chronic Headache
Worksheet removed
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
